Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 240.8
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Trident Lifeline Ltd. manufactures and markets pharmaceutical products. It is engaged in the pharmaceutical business ethical marketing in domestic as well as international market. The firm offers pharmaceutical formulations and products manufactured on contract manufacturing under loan licence. The company was founded on January 9, 2014 and is headquartered in Surat, India.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBIT
Data is available to registered users only
Buy
Sell